Hints and tips:
...Merck has agreed to buy Prometheus Biosciences for $10.8bn as the US drugmaker bolsters it pipeline ahead of the possible loss of exclusivity over its best-selling cancer drug later this decade....
...One reason why synthetic tests have not been more widely adopted is a lack of standards on the use of rFC, according to Lonza, the Swiss-based biosciences company which has developed an alternative test....
...On Sunday, Merck announced that it would acquire Prometheus Biosciences for $10.8bn. It is paying Prometheus shareholders a 72 per cent premium over the three-month average share price....
...Privately owned Firmenich last year announced a €41bn plan to merge with the Dutch ingredients and bioscience group DSM, which was approved by DSM shareholders in January....
...In January 2020, it was forced to abandon its $1.2bn takeover of rival Pacific Biosciences following opposition from regulators....
...Novavax’s Stanley Erck will be replaced by John C Jacobs, most recently chief executive at Harmony Biosciences, this month; CureVac’s Franz-Werner Haas will be succeeded by Alexander Zehnder, a Sanofi veteran...
...The Future Fund has also taken stakes in advanced materials group Oxford Nanosystems, biotech firm Roslin Technologies, online pharmacy Phlo Technologies, Magnitude Biosciences, a life sciences company,...
...“We know that once you are infected with RSV you can no longer prime for that exacerbated response with a vaccine,” said Jason McLellan, professor of molecular biosciences at the University of Texas....
...The ruling could set a significant precedent because it extends Brussels’ reach over deals in sectors such as technology and biosciences that potentially damage European rivals, adding an extra level of...
...Andrey Zarur, head of GreenLight Biosciences, said ingredients stockpiled ahead of vaccine approvals would supply the first 1bn-2bn doses, but bottlenecks would emerge after that....
...Zhao declined to comment. 12) Telis Bioscience ($1mn for 2pc) CEO Grigory Khimulya says Telis Bioscience is “a venture-backed biotech company in Cambridge, MA engineering high-impact protein therapeutics...
...In trials, an oral antiviral made by Chinese company Shanghai Junshi Biosciences outperformed Paxlovid, cutting the median time to recovery....
...“We look forward to being an active participant in the UK's bioscience community.”...
...A version of this article was first published by Nikkei Asia on July 22. ©2022 Nikkei Inc. All rights reserved....
...SK Bioscience’s IPO was the biggest in South Korea since gaming company Netmarble’s Won2.7tn float in 2017....
...Its action comes after the agency sued to block Illumina’s purchase of a more direct rival, Pacific Biosciences — a transaction ultimately abandoned....
...Biotech companies including Seegene, Celltrion Healthcare and Hyundai Bioscience as well as gaming groups such as Kakao Games have also been targeted by bearish investors....
...Ilumina has been burnt by regulators before, calling off a $1.2bn merger with Pacific Biosciences last year when competition watchdogs in the UK and the US investigated whether the combined company could...
...Steve Bates, chief executive of the BioIndustry Association, a British bioscience lobby group, said: “This work shows again the strength of the UK life sciences and biotech sector which has been at the forefront...
...The supply of lipid nanoparticles is “fairly restricted” in Europe, said Andrey Zarur, chief executive of GreenLight BioSciences, a Massachusetts-based company that works with messenger RNA, including in...
...One alternative I am looking at is a listed biosciences investor called Arix, which came to the market in 2017....
...DNA sequencing company Illumina called off a $1.2bn merger with smaller rival Pacific Biosciences on Thursday following scrutiny of the deal by competition watchdogs in the UK and the US who feared the two...
...Mr Frazier’s comments came as Merck announced it was acquiring Themis Bioscience, a privately held biotech company based in Vienna that has been developing a coronavirus vaccine....
...One retained the name DuPont, of which the nutrition and biosciences was part — until the deal announced on Sunday....
...Crispr comes up with 4x faster testMammoth Biosciences has used Crispr gene-editing tech to come up with a Covid-19 test that can produce a result in 30 minutes and be the size of a pregnancy-testing kit...
International Edition